Caris Life Sciences (CAI) Research & Development (2024 - 2026)

Caris Life Sciences' Research & Development history runs 3 years deep, the most recent figure standing at $31.3 million for Q1 2026.

• In Q1 2026, Research & Development rose 35.76% year-over-year to $31.3 million; the TTM figure through Mar 2026 stood at $109.8 million (up 7.04% YoY), while the FY2025 annual figure was $101.6 million, down 10.83% from the prior year.
• Research & Development was $31.3 million for Q1 2026 at Caris Life Sciences, down from $31.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $31.8 million in Q4 2025 to a low of $21.6 million in Q3 2025.
• Historically, Research & Development has averaged $26.6 million across 3 years, with a median of $26.1 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Research & Development retreated 21.78% in 2025, then soared 35.76% in 2026.
• A 3-year view of Research & Development shows it stood at $27.1 million in 2024, then increased by 17.47% to $31.8 million in 2025, then decreased by 1.66% to $31.3 million in 2026.
• The last three Research & Development figures came in at $31.3 million (Q1 2026), $31.8 million (Q4 2025), and $21.6 million (Q3 2025), per Business Quant data.